Non-financial Assets and Liabilities (Tables)

12 Months Ended

Jun. 30, 2026

Non-Financial Assets and Liabilities [Abstract]

Schedule of Intangible Assets

(a) Intangible assets

		AVb6 Integrin				hu PSA Anti-body				NanoMab				MAb				Pharma 15				Pivalate				Other Intellectual Property				Total
		$				$				$				$				$				$				$				$
Year ended 30 June 2026
Opening net book amount			14,179,639				9,654,514				15,596,071				1,229,761				5,445,016				246,614				222,807				46,574,422
Sale of asset(note 6(a)			-				-				-				-				-				-				-				-
Exchange difference			-				-				-				(56,188	)			(178,193	)			-				-				(234,381	)
Amortization charge			(884,592	)			(741,732	)			(973,548	)			(66,388	)			-				(22,404	)			(10,038	)			(2,698,702	)
Impairment charge											-				-				(5,266,823	)			-				(212,769	)			(5,479,592	)
Closing net book amount			13,295,047				8,912,782				14,622,523				1,107,185				-				224,210				-				38,161,747

At 30 June 2026
Cost			17,691,796				16,212,081				19,470,972				1,374,030				6,940,599				336,055				275,415				62,300,948
Exchange difference			-				-				-				(63,810	)			(320,127	)			-				-				(383 937)
Accumulation amortization and impairment			(4,396,749	)			(7,299,299	)			(4,848,449	)			(203,035	)			(6,620,472	)			(111,845	)			(275,415	)			(23,755,264	)
Net book amount			13,295,047				8,912,782				14,622,523				1,107,185				-				224,210				-				38,161 747

		AVb6 Integrin				hu PSA Anti-body				NanoMab				MAb				Pharma 15				Pivalate				Other Intellectual Property				Total
		$				$				$				$				$				$				$				$
Year ended 30 June 2025
Opening net book amount			15,064,229				10,275,699				16,569,620				1,283,925				5,384,777				269,018				240,020				49,087,288
Sale of asset (note 6(a))			-				-				-				-				-				-				-				-
Exchange differences			-				-				-				15,201				60,239				-				-				75,440
Amortization charge			(884,590	)			(621,185	)			(973,549	)			(69,365	)			-				(22,404	)			(17,213	)			(2,588,306	)
Impairment charge			-				-				-				-				-				-				-				-
losing net book amount			14,179,639				9,654,514				15,596,071				1,229,761				5,445,016				246,614				222,807				46,574,422

At 30 June 2025
Cost			17,691,796				16,212,081				19,470,972				1,374,030				6,940,599				336,055				275,415				62,300,948
Accumulated amortization and impairment			(3,512,157	)			(6,557,567	)			(3,874,901	)			(144,269	)			(1,495,583	)			(89,441	)			(52,608	)			(15,726,526	)
Net book amount			14,179,639				9,654,514				15,596,071				1,229,761				5,445,016				246,614				222,807				46,574,422

Schedule of Employee Benefit Obligations

(c) Employee benefit obligations

		30 June 2026												30 June 2025												30 June 2024
		Current				Non- current				Total				Current				Non- current				Total				Current				Non- current				Total
		$				$				$				$				$				$				$				$				$
Leave obligations (i)			697,907				-				697,907				450,104				-				450,104				399,788				-				399,788

(i) Leave obligations